Text this: WCN24-2141 HOW DOES THE USE OF CONTINUOUS GLUCOSE MONITORING DIFFER AMONG PEOPLE WITH ESKD AFTER KIDNEY TRANSPLANTATION, ON HEMODIALYSIS, AND ON PERITONEAL DIALYSIS?